The C(-1019)G 5-HT1A promoter polymorphism and personality traits: no evidence for significant association in alcoholic patients by Koller, G et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Behavioral and Brain Functions
Open Access Research
The C(-1019)G 5-HT1A promoter polymorphism and personality 
traits: no evidence for significant association in alcoholic patients
G Koller*1, B Bondy2, UW Preuss3, P Zill2 and M Soyka4
Address: 1Psychiatrische Klinik der LMU, Substitutionsambulanz, Pestalozzistraße 2, D-80469 München, Germany, 2Psychiatrische Klinik der 
LMU, Neurochemie, Nußbaumstraße 7, D-80336 München, Germany, 3Johanna-Odebrecht-Stiftung, Gützkower Landstraße 69, D-17489 
Greifswald, Germany and 4Psychiatrische Klinik der LMU, Nussbaumstrasse 7, D-80336 München, Germany
Email: G Koller* - gabi.koller@med.uni-muenchen.de; B Bondy - brigitta.bondy@med.uni-muenchen.de; 
UW Preuss - ulrich_preuss@hotmail.com; P Zill - peter.zill@med.uni-muenchen.de; M Soyka - michael.soyka@med.uni-muenchen.de
* Corresponding author    
Abstract
The 5HT1A receptor is one of at least 14 different receptors for serotonin which has a role in
moderating several brain functions and may be involved in the aetiology of several psychiatric
disorders. The C(-1019)G 5-HT1A promoter polymorphism was reported to be associated with
major depression, depression-related personality traits and suicidal behavior in various samples.
The G(-1019) allele carriers are prone to depressive personality traits and suicidal behavior,
because serotonergic neurotransmission is reduced.
The aim of this study is to replicate previous findings in a sample of 185 Alcohol-dependent
individuals. Personality traits were evaluated using the NEO FFI and TCI. History of suicidal
behavior was assessed by a standardized semistructured interview (SSAGA). No significant
differences across C(-1019)G 5-HT1A genotype groups were found for TCI temperament and
character traits and for NEO FFI personality scales. No association was detected between this
genetic variant and history of suicide attempts. These results neither support a role of C(-1019)G
5-HT1A promoter polymorphism in the disposition of personality traits like harm avoidance or
neuroticism, nor confirm previous research reporting an involvement of the G allele in suicidal
behavior in alcoholics. Significant associations, however, were detected between Babor's Type B
with number of suicide attempts in history, high neuroticism and harm avoidance scores in
alcoholics.
Background
The 5-hydroxytryptamine 1A receptor (5-HT1A) is one of
several different receptors for 5-hydroxytryptamine (sero-
tonin). Serotonin has a role in moderating several brain
functions and is involved in the aetiology of several psy-
chiatric disorders. Evidence for a role of 5-HT1A receptor
in the pathophysiology of anxiety and depression has
come from several clinical studies as well as from animal
models [1-3]. In animal models, 5-HT1A receptor-defi-
cient animals have been reported to have an increased
level of anxiety and stress response as well as decreased
exploratory activity [4,5]. The 5-HT1A receptor is also sug-
gested to be involved in the response to antidepressant
and anxiolytic drugs [6,7].
The 5-HT1A receptor is an integral membrane protein and
belongs to the family of G-protein coupled receptors that
inhibit adenylate cyclase activity. Negative feedback inhi-
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bition of serotonergic raphe neurons is mediated by som-
atodendritic 5-HT1A autoreceptors [8,9]. Reduced
serotonergic neurotransmission is implicated in the
pathogenesis of depressive illness and suicidal behaviors
[10]. The gene for the 5-HT1A receptor is located at chro-
mosomal region 5q11.2-q13 [11]. Human 5-HT1A gene
transcription is modulated by a common C(-1019)G sin-
gle nucleotide polymorphism (SNP) in its upstream regu-
latory region. The C(-1019) allele is part of a 26 bp
imperfect palindrome that binds transcription factors
NUDR (nuclear deformed epidermal auto regulatory fac-
tor) whereas the G(-1019) allele abolishes repression by
NUDR, but only partially impairs Hes5-mediated repres-
sion. It was suggested that the G(-1019) allele derepresses
5-HT1A auto receptor expressions to reduce serotonergic
neurotransmission [12].
Previous studies reported an association of the C(-1019)G
5-HT1A-promoter polymorphism with major depression
and suicide in a number of samples.
There is a close relationship between the diagnosis depres-
sion and certain personality traits. The personality charac-
teristic neuroticism and the temperament trait harm
avoidance seem to be most interesting in this field. Neu-
roticism is described to be related with anxiety and
depression [13]. Regarding temperament traits, harm
avoidance have also been reported to be associated with
anxiety and depression [14]. As there is a close relation-
ship between character and personality traits to depressive
and anxiety symptoms, the role of C(-1019)G 5-HT1A
polymorphism in modulating these personality traits was
evaluated to investigate the biological underpinnings of
these important characteristics.
A significant effect of the C(-1019)G 5-HT1A polymor-
phism on neuroticism was detected with carriers of the G
allele having higher scores than individuals homozygous
for the C nucleotide. Carriers of the G allele also exhibited
higher harm avoidance scores than carriers of the C allele
[15].
Since suicidal behaviour is one of the diagnostic criteria
for depression, a relationship between suicidal behavior
and 5-HT1A receptor genetic variants can be expected but
conflicting results were reported [16].
Persistent alterations in neuroendocrine responsiveness
of both 5-HT and noradrenergic systems in alcoholic
patients are documented [17]. Thus, an investigation of
the influence of C(-1019)G 5-HT1A-promoter polymor-
phism on anxiety and depression-related personality traits
in alcohol-dependent individuals might be of interest.
This manuscript represents an association study in a new
population-German alcoholics. Suicide in a pure alco-
holic sample is thought to have similar etiology to suicide
in a depression sample.
The aim of our study is to investigate the C(-1019)G 5-
HT1A-promoter polymorphism and its possible associa-
tion with anxiety and depression-related personality traits
and suicidal behavior. We hypothesize a significant effect
of the C(-1019)G 5-HT1A polymorphism on neuroticism
with carriers of the G allele having higher scores than indi-
viduals homozygous for the C variant as well as carriers of
the G allele showing higher harm avoidance scores. Fur-
thermore we hypothesize carriers of the G allele showing
more suicide attempts in history. Since the severity of
alcohol dependence and psychopathology differ in sub-
types of alcoholics, potential interactions with Babor's
Type A/ B subtypes were also investigatated.
Methods
Study design
From the addiction treatment ward of the psychiatric hos-
pital at the University of Munich, 185 treatment-seeking
individuals were recruited. All patients were unrelated, of
German descent, older than 18 years and met ICD-10 and
DSM-IV criteria for alcohol dependence, assessed with the
structured clinical interview DSM IV [18] and SSAGA
(Semi-Structured Assessment on the genetics in alcohol-
ism) [19,20]. The diagnostic assessment was performed
without knowledge of genotype data.
All patients were assessed two weeks after admission and
after completing alcohol withdrawal, being free of any
psychopharmacologic treatment for an average of 1.5 +0.6
weeks. Alcohol-dependent patients were excluded if they
had a history of an independent major psychiatric disor-
der (occurring before the onset of alcohol dependence or
during prolonged periods of abstinence) or substance
dependence other than alcohol, marijuana or nicotine.
Informed written consent was obtained from patients
after complete and extensive description of the study. The
study was approved by the ethical committee of the Lud-
wig-Maximilians University of Munich in agreement with
the principles laid down in the Helsinki Declaration
(1964).
All participants completed the German version of Neo FFI
and TCI [21,22]. The NEO Five-Factor Inventory is a short-
ened version of the NEO-PI, designed to give quick, relia-
ble and valid measures of the five domains of adult
personality including Neuroticism, Openness, Extraver-
sion, Agreeableness and Consciousness. The 60 items are
rated on a five-point scale. The NEO-FFI has a grade six
reading level, and requires 10–15 minutes to completeBehavioral and Brain Functions 2006, 2:7 http://www.behavioralandbrainfunctions.com/content/2/1/7
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[23]. The Temperament and Character Inventory (TCI) is
a self-rating questionnaire designed to quantify individual
differences on each of the temperament (Harm avoidance,
Novelty seeking, Reward dependence and character
dimension (Resistance, Self-directedness, Cooperation,
Self-transcendence) [24]. Diagnostic and sampling proce-
dure and research instruments were also described in pre-
vious publications [25,26].
Withdrawal symptomatology as well as a history of sui-
cide attempts were evaluated using the SSAGA (Semi-
Structured Assessment on the genetics in alcoholism
[19,20].
Alcohol-dependent patients were classified as Type A or
Type B using Babor Typology [27], using the criteria of
Schuckit [28]. Characteristics of alcohol dependence,
including the five characteristics mentioned by Schuckit
were assessed using the SSAGA. These characteristics
included daily alcohol intake (drinks of alcohol per drink-
ing day (g/d), relief drinking, medical conditions due to
alcohol, and physical and social consequences. Taking
SSAGA data, composite scales were calculated for the five
characteristics and dichotomised using median split. The
5 items were normalized prior to creating a composite
scale. Subjects were subtyped according to Type A or B if
they met three or more of the dichotomised scores criteria
(upper half: Type B, lower half Type A).
Genotyping
Genomic DNA was isolated from whole blood according
to standard procedures. All genotyping was performed
with the fluorescence resonance energy transfer method
(FRET) using the Light Cycler System (Roche Diagnostics,
Mannheim, Germany). A detailed description of the theo-
retical background and methodology is given [29]. For the
C-1019G polymorphism in the 5HT1A receptor gene the
following conditions were applied. Forward primer: 5'-
CCG TTT TGT TGT TGT TGT CG-3'; reverse primer: 5'-CCA
GCA AAA CTG GGG TTG3'; donor hybridization probe:
5'-TTT AAA AAC GAA GAC ACA CTC-fluorescein-3';
acceptor hybridization probe:
5'-LCRed640-CTT CTT CCA TCA ATT AGC AAT AAT TGG
GAG-3'. PCR was performed with 50 ng DNA in a total
volume of 20 μl containing 2 μl reaction mix, 0.5 μM each
primer, 0.2 μM each hybridization probe and 2 μM MgCl2
according to the manufacturer's instructions for 35 cycles
of denaturation (95°C, 0 s, ramp rate 20°C/s), annealing
(55%°C, 10 s, ramp rate 20°C/s) and extension (72°C,
10 s, ramp rate 20°C/s). After amplification a melting
curve was generated by holding the reaction at 40°C for
20 s and then heating slowly to 95°C with a ramp rate of
0.2°C/s. The fluorescence signal was plotted against tem-
perature to give melting curves for each sample. Peaks
were obtained at 57°C for the C-allele and at 46°C for the
G-allele. All laboratory procedures were carried out blind
to diagnostic assessment.
Statistical analyses
To analyze relationships between personality traits and
suicidal behavior with 5-HT1A genotypes and subtypes of
alcoholics in a single model, a single MANOVA (multivar-
iate analysis of variance) was performed. Suicide attempts
in history, neuroticism and harm avoidance were used as
dependent variables, C(-1019)G 5-HT1A and Babor
Typology were used as independent factors. A p-value of
<0.05 (2-tailed) was considered as statistically significant.
Results
A total of 185 alcohol-dependent individuals were
enrolled into the study. Sample characteristics are pre-
sented in table 1.
Using a single MANOVA no significant association was
detected between C(-1019)G 5-HT1A and suicide attempt
in history (F = 0.230, p = 0.795, df = 2), between C(-
1019)G 5-HT1A and neuroticism (F = 0.811, p = 0.446, df
= 2) and between C(-1019)G 5-HT1A and harm avoid-
ance (F = 0.268, p = 0.765, df = 2).
However, significant associations were found between
Babor's Type A/B and suicide attempts in history (F =
9.299, p = 0.003, df = 1), neuroticism (F = 9.857, p =
0.002, df = 1) and harm avoidance (F = 5.383, p = 0.022,
df = 1). Type B shows higher neuroticism scores, as well as
Table 1: Sample characteristics
Male Female
Number 150 (81,1%) 35 (18.9%)
Mean Age 41.6 ± 9,69 41,5 ± 3,56
Mean age of onset 28,56 ± 8,55 31,8 ± 8,77
Mean alcohol intake (g per day) 360,75 ± 199,8 216,15 ± 108,33
Type A 97 (52,4%) 25 (13,5%)
Type B 53 (28,6%) 10 (5,5%)
At last one suicide attempt in history 31 (16,7%) 10 (5,4%)Behavioral and Brain Functions 2006, 2:7 http://www.behavioralandbrainfunctions.com/content/2/1/7
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higher harm avoidance scores and a more frequent
amount of suicide attempts in history.
No significant interaction between C(-1019)G 5-HT1A
and Babor Typology in suicide attempts (F = 1.220, p =
0.298, df = 2), between C(-1019)G 5-HT1A and Babor
Typology and neuroticism (F = 0.763, p = 0.468, df = 2)
and between C(-1019)G 5-HT1A and Babor Typology and
harm avoidance (F = 0.803, p = 0.450, df = 2) could be
detected (s.table 2).
Discussion
The present study re-examined the potential association
of a functional 5-HT1A-receptor polymorphism, a history
of suicide attempts, and personality traits of harm avoid-
ance and neuroticism. Our results do not support an asso-
ciation between the C(-1019)G 5-HT1A-promoter
polymorphism with these personality and temperament
traits, and also failed to detect an association between this
functional polymorphism and a history of suicide
attempts in 185 alcohol-dependent individuals. Signifi-
cant associations were found between Babor's Type B and
increased number of suicide attempts in history as well as
higher neuroticism and harm avoidance scores.
The only previous study reporting an association between
personality traits and this polymorphism in individuals of
Caucasian background described the C(-1019)G 5-HT1A
promoter polymorphism to be associated with the per-
sonality traits harm avoidance and neuroticism [15]. In
accord with our assessments, in this prior study personal-
ity traits were assessed by NEO-PIR and TPQ.
The NEO FFI has five dimensions; their mean and stand-
ard deviation reference values in German population were
described by authors of the German version [21]. The
scale Harm avoidance is in line with a low score in self-
directedness reflecting low responsibility, low purposeful-
ness, low resourcefulness, low self-acceptance and low
congruent second nature [30].
Thus, the divergent results deserve comments. The con-
ceptual frame of anxiety-and depression-related personal-
ity traits and its assessment in alcoholics shortly after
alcohol detoxification may be a relevant factor influenc-
ing the results.
The association of the G allele with certain personality
traits may be different in subjects affected by other psychi-
atric disorders. For an association between suicide
attempts and C(-1019)G 5-HT1A-promoter polymor-
phism the power of our sample might be too low (41 indi-
viduals reported a history of suicide attempts). Suicidal
behaviour in general may be too heterogeneous to be a
suitable phenotype to demonstrate genetic influence of
single polymorphisms. Another limitation of the study is
that participants were drug free only for 1,5 ± 0,6 weeks
before the study but the 5-HT1A autoreceptor take 2–3
weeks to desensitise [31]. Reinvestigation of the partici-
pants after a longer drug free interval could be helpful.
Furthermore, it is not unusual that results of association
studies significantly depend on the assessment method,
i.e. the type of questionnaires and tests used. In a recent
meta-analysis contrasts between groups were shown to be
significant for TCI/TPQ Harm avoidance but not for NEO
Neuroticism [32]. This may indicate more heterogeneity
for the phenotype
Another meta-analysis reported significant effects on 5-
HTTLPR. For studies using the Neuroticism scale of Costa
and McCrae [33]. Findings do indicate that the effect, if
present, is small.
There are also effects from other parts of the serotonergic
system on the 5-HT1A receptor. In a very recent study it
was demonstrated for the first time that a functional pol-
ymorphism in the 5-HTT gene, but not the 5-HT1A-recep-
tor gene itself, affects 5-HT1A receptor availability in man.
The 5-HT1A-receptor genotype did not show any signifi-
cant effects on [11C]WAY 100635 binding [34]. These
results may explain our results as far as functional signifi-
cance is not as predicted.
Patients with panic disorder and depression exhibit an
attenuation of 5-HT1A receptor-mediated neuroendo-
crine response, reflecting dysfunction of pre and postsyn-
aptic 5-HT1A receptors [35]. Subsequent studies
suggested the same mechanism to be associated with ago-
raphobia in a group of patients with panic disorders [36].
Decreased ligand binding of 5-HT1A receptors has been
shown in depressed patients [37].
Table 2: Total numbers, Means of Neuroticism and Harm avoidance and numbers of patients with suicide attempts in history grouped 
by GG, GC and CC and by Babor Typology(SD = Standard deviation)
GG Type A GG Type B GC Type A GC Type B CC Type A CC Type B
Number of patients 30 (16,2%) 15 (8,1%) 62 (33,5%) 32 (17,2%) 30 (16,2%) 16 (8,6%)
Neuroticism score (Mean/SD) 22,6 ± 8 28,2 ± 8 23,3 ± 8 27,3 ± 8 22,1 ± 6 25,1 ± 8
Harm avoidance score (Mean/SD) 16,1 ± 6 19,7 ± 6 15,9 ± 6 18,0 ± 6 16,2 ± 6 17,4 ± 5
Suicide attempts in history (Number of patients) 4 (2,1%) 7 (3,7%) 11 (5,9%) 10 (5,4%) 3 (1,6%) 6 (3,2%)Behavioral and Brain Functions 2006, 2:7 http://www.behavioralandbrainfunctions.com/content/2/1/7
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Not much data are available about association of person-
ality traits and C(-1019)G 5-HT1A-promoter polymor-
phism. Regarding an association between the C(-1019)G
5-HT1A-promoter polymorphism and suicidal behavior,
a recent study detected a significant association between
this polymorphism and completed suicide [12]. However,
the Pro16Leu and Gly272Asp polymorphisms of the 5-
HT1A receptor gene failed to show an association with
completed suicide in another study [38].
Since not much data are available in this field additional
data may provide additional support or fail to support the
hypothesis. Use of haplotypes for a particular gene or a
broader assessment of serotonergic genes is mentioned as
a stronger methodology.
Conclusion
In conclusion our data failed to show the previously
described association between the C(-1019)G 5-HT1A-
promoter polymorphism and certain personality traits,
which are depression- and anxiety-related. Our data also
do not support an association between C(-1019)G 5-
HT1A-promoter polymorphism and a history of suicide
attempts. Further studies should address some of the open
questions that remain. Another possible issue is whether
therapeutic response to serotonergic agents is influenced
by this polymorphism. Significant association is shown
between Babor's Type B and number of suicide attempts
in history, higher neuroticism and harm avoidance scores.
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